Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Immune Checkpoint Inhibitors in the Treatment of Hematologic Malignancies: An Umbrella Review of Systematic Reviews and Meta-Analyses.

Cancer medicine·2026
Same author

Haploidentical allogeneic haematopoietic stem cell transplantation for paroxysmal nocturnal haemoglobinuria: a retrospective analysis.

Annals of hematology·2026
Same author

Mecapegfilgrastim for Prophylaxis of Immunochemotherapy-Induced Neutropenia in Patients With Diffuse Large B-Cell Lymphoma: A Multicenter Pilot Trial.

Cancer medicine·2026
Same author

Epicardial adipose tissue volume stratifies atrial fibrillation subtypes in reduced ejection fraction heart failure: a CT-based predictor.

Frontiers in cardiovascular medicine·2026
Same author

The diagnostic and prognostic utility of blood metagenomic next-generation sequencing for invasive pulmonary aspergillosis.

Microbiology spectrum·2026
Same author

Chronic graft-versus-host disease after haploidentical transplantation in aplastic anemia: clinical characteristics, risk factors, and survival outcomes.

Bone marrow transplantation·2026

Related Experiment Video

Updated: Sep 20, 2025

Autologous Blood Injection to Model Spontaneous Intracerebral Hemorrhage in Mice
07:02

Autologous Blood Injection to Model Spontaneous Intracerebral Hemorrhage in Mice

Published on: August 24, 2011

15.0K

Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter study.

Shan Chong1,2,3,4, Peng Zhao1,2,3,4, Rui-Bin Huang5

  • 1Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.

Blood Advances
|June 9, 2022
PubMed
Summary
This summary is machine-generated.

Intracranial hemorrhage (ICH) in immune thrombocytopenia (ITP) patients has a high mortality rate. This study identified key risk factors and developed a prognostic model to predict 30-day survival for ICH in ITP adults.

More Related Videos

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
09:41

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage

Published on: July 3, 2014

15.0K
A Low Mortality Rat Model to Assess Delayed Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage
07:03

A Low Mortality Rat Model to Assess Delayed Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage

Published on: January 17, 2013

14.5K

Related Experiment Videos

Last Updated: Sep 20, 2025

Autologous Blood Injection to Model Spontaneous Intracerebral Hemorrhage in Mice
07:02

Autologous Blood Injection to Model Spontaneous Intracerebral Hemorrhage in Mice

Published on: August 24, 2011

15.0K
Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
09:41

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage

Published on: July 3, 2014

15.0K
A Low Mortality Rat Model to Assess Delayed Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage
07:03

A Low Mortality Rat Model to Assess Delayed Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage

Published on: January 17, 2013

14.5K

Area of Science:

  • Hematology
  • Neurology
  • Critical Care Medicine

Background:

  • Immune thrombocytopenia (ITP) patients face a rare but life-threatening risk of intracranial hemorrhage (ICH).
  • Limited understanding exists regarding the mortality rates and associated risk factors for ICH in this patient population.

Purpose of the Study:

  • To determine the mortality rate of ICH in adult ITP patients.
  • To identify significant risk factors for 30-day mortality following ICH in adult ITP patients.
  • To develop and validate a prognostic model for predicting 30-day mortality.

Main Methods:

  • A nationwide, multicenter, real-world study utilizing data from 27 centers in China (2005-2020).
  • Logistic regression analysis was employed to identify risk factors in a training cohort (n=107).
  • Internal validation via bootstrap and external validation using a separate test cohort (n=35) were performed.

Main Results:

  • The overall mortality rate for ICH in adult ITP patients was 33.80%.
  • Identified risk factors for 30-day mortality included intraparenchymal hemorrhage (IPH), low platelet count (≤10 × 10^9/L), serious infections, bleeding event severity, and Glasgow Coma Scale (GCS) score.
  • The developed prognostic model demonstrated high predictive accuracy (AUC 0.954 internal, 0.942 external) and good calibration.

Conclusions:

  • A significant mortality risk exists for ICH in adult ITP patients.
  • A validated prognostic model and a predictive application were developed to aid in assessing 30-day mortality risk.
  • These tools can assist clinicians in managing ICH in ITP patients.